Rystiggo (rozanolixizumab-noli)

$9,803.03

This medicine requires a prescription. See “Prescription Guide”.

We can only help if the medicine is not available in your country. Learn more.

Rystiggo (rozanolixizumab-noli) is a prescription medicine for adult patients with generalized myasthenia gravis (gMG). It is indicated for patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive 1.

Rystiggo (rozanolixizumab-noli) is approved by the FDA in the USA 2.